CBC News
@CBCNews·4.7M subscribers·47K videos
Alzheimer's drug hailed as breakthrough, but may have side effects
Posted
December 1, 2022
Views
15,791
Likes
116
Comments
37
Engagement
0.97%
December 1, 2022
15,791
116
37
0.97%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:38Now PlayingAn experimental drug for Alzheimer's disease slowed cognitive decline in a closely watched trial, but may carry a risk of dangerous side effects for certain patients. However, Dr. Donald Weaver, senior scientist at the University Hospital Network's Krembil Brain Institute in Toronto, still calls it a 'step in the right direction.'
»»» Subscribe to CBC News to watch more videos
Connect with CBC News Online:
For breaking news, video, audio and indepth coverage
Find CBC News on Facebook
Follow CBC News on Twitter
For breaking news on Twitter
Follow CBC News on Instagram
Subscribe to CBC News on Snapchat
Download the CBC News app for iOS
Download the CBC News app for Android
»»»»»»»»»»»»»»»»»»
For more than 80 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
